Target engagement imaging of PARP inhibitors in small-cell lung cancer

Insufficient chemotherapy response and rapid disease progression remain concerns for small-cell lung cancer (SCLC). Oncologists rely on serial CT scanning to guide treatment decisions, but this cannot assess in vivo target engagement of therapeutic agents. Biomarker assessments in biopsy material do...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Nat Commun
Egile Nagusiak: Carney, Brandon, Kossatz, Susanne, Lok, Benjamin H., Schneeberger, Valentina, Gangangari, Kishore K., Pillarsetty, Naga Vara Kishore, Weber, Wolfgang A., Rudin, Charles M., Poirier, John T., Reiner, Thomas
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5766608/
https://ncbi.nlm.nih.gov/pubmed/29330466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-017-02096-w
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak